Used as a key intermediate in the synthesis of certain pharmaceutical agents, particularly in the development of cannabinoid receptor modulators. Its structural features, including the 2,2-difluoro cyclopropane moiety, allow for enhanced metabolic stability and binding affinity, making it valuable in optimizing drug candidates for neurological and inflammatory conditions. Commonly employed in medicinal chemistry research to improve pharmacokinetic properties in target molecules.